Company intelligence
Network Bio
AI Trained on Patient Tissue at Scale
22 employees
1 public signals
About Network Bio
Network Bio builds AI for medicine on the world's largest patient tissue training dataset, linked to blood samples and clinical outcomes from top US academic biobanks. We’re backed by top-tier investors S32, Thiel Bio, Founders Fund, Blue Venture Fund, and Breyer Capital.
Verified activity
Signals from Network Bio
1 published signal